These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17531556

  • 1. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH.
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov 15; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 7. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F.
    Am J Gastroenterol; 2009 Oct 15; 104(10):2508-16. PubMed ID: 19532127
    [Abstract] [Full Text] [Related]

  • 8. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, Iacob S, Constantinescu I, Gheorghe L, Iobagiu S, Gheorghe C, Diculescu M.
    J Gastrointestin Liver Dis; 2012 Mar 15; 21(1):39-44. PubMed ID: 22457858
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C, Chapelle JP, Lutteri L.
    Ann Biol Clin (Paris); 2007 Mar 15; 65(6):601-8. PubMed ID: 18039604
    [Abstract] [Full Text] [Related]

  • 10. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, Vogelsang H, Reinisch W.
    Am J Gastroenterol; 2003 Oct 15; 98(10):2226-31. PubMed ID: 14572572
    [Abstract] [Full Text] [Related]

  • 11. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D.
    Scand J Gastroenterol; 2007 Jun 15; 42(6):717-25. PubMed ID: 17505994
    [Abstract] [Full Text] [Related]

  • 12. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
    Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):881-7. PubMed ID: 15801923
    [Abstract] [Full Text] [Related]

  • 13. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
    Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, Mallet JM, Colombel JF, Poulain D.
    Gastroenterology; 2006 May 01; 130(6):1764-75. PubMed ID: 16697740
    [Abstract] [Full Text] [Related]

  • 14. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
    Amre DK, Lu SE, Costea F, Seidman EG.
    Am J Gastroenterol; 2006 Mar 01; 101(3):645-52. PubMed ID: 16464223
    [Abstract] [Full Text] [Related]

  • 15. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
    Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J.
    Am J Gastroenterol; 2004 Dec 01; 99(12):2376-84. PubMed ID: 15571586
    [Abstract] [Full Text] [Related]

  • 16. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
    Preda CM, Diculescu M, Mirea V, Marica C, Vermeire S, Rutgeerts P, Oproiu A.
    Rom J Gastroenterol; 2005 Mar 01; 14(1):23-6. PubMed ID: 15800689
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M, Papa A, Nista EC, Danese S, Armuzzi A, Bartolozzi F, Tondi P, Ojetti V, Gasbarrini G, Gasbarrini A.
    Hepatogastroenterology; 2003 Mar 01; 50(51):718-20. PubMed ID: 12828069
    [Abstract] [Full Text] [Related]

  • 18. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D.
    Am J Gastroenterol; 2008 Apr 01; 103(4):949-57. PubMed ID: 18047546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.